Developmental Research Program (DRP)
Developmental Research Program (DRP)
批准号:
10469378
负责人:
URSULA Anne MATULONIS
金额:
$29.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-08-03 至 2025-07-31
关键词:
AdvocateAttentionAwardBudgetsCancer CenterComplementDevelopmentDiagnosisEarly DiagnosisEnsureEquilibriumEvaluationFacultyFosteringFundingGoalsGrantInstitutionMalignant neoplasm of ovaryMentorsMentorshipMethodsMinorityMinority WomenMissionMonitorPilot ProjectsPreventionProcessProductivityProgram Research Project GrantsProgress ReportsRequest for ApplicationsResearchResearch ActivityResearch PersonnelResistanceResourcesSpecific qualifier valueTimeLineTranslational ResearchWomanbasecommunity centerhigh riskinnovationnovelprogramsresearch and developmentsoundsuccesstranslational potential
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT - DEVELOPMENTAL RESEARCH PROGRAM RESEARCH PLAN
The overall goals of the Dana-Farber/Harvard Cancer Center (DF/HCC) Ovarian Cancer SPORE
Developmental Research Program (DRP) are to support high risk/high potential pilot projects that take
maximum advantage of new research opportunities within the DF/HCC Ovarian Cancer SPORE and to
maintain this Program throughout the entire grant term. The selection and monitoring process will be led by
the DRP Directors, Drs. Ursula Matulonis, Stephen Cannistra and Alan D’Andrea, with oversight from the other
SPORE leader, Dr. Spriggs. The DF/HCC Ovarian Cancer DRP Executive Committee (EC) which is
comprised on the DF/HCC SPORE committee, the External Advisory Board, the Internal Advisory Board (IAB)
and the Ovarian Cancer Advocate Core of this Ovarian Cancer SPORE Project will directly participate in the
review, scoring and selection of DRP Projects. The DRP will encourage applications from minorities and
women as well as high risk/high payoff projects. Full access to DF/HCC Ovarian Cancer SPORE resources
including Core access will be available to DRP Projects. Those projects that have demonstrated great
progress and translational research potential will have the potential to become full SPORE Projects but only
with the approval of the DF/HCC Ovarian Cancer DRP EC. Funding for the DRP is comprised partly from the
Ovarian Cancer SPORE budget as well as significantly from DF/HCC institutions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of the Efficacy of Trametinib + Navitoclax in recurrent ovarian carcinoma
-
批准号:10024420
-
项目类别:
-
资助金额:$42.92万
-
财政年份:2020
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Developmental Research Program (DRP)
-
批准号:10684241
-
项目类别:
-
资助金额:$14.97万
-
财政年份:2020
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Developmental Research Program (DRP)
-
批准号:10228055
-
项目类别:
-
资助金额:$15.18万
-
财政年份:2020
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Evaluation of the Efficacy of Trametinib + Navitoclax in recurrent ovarian carcinoma
-
批准号:10228054
-
项目类别:
-
资助金额:$38.55万
-
财政年份:2020
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Evaluation of the Efficacy of Trametinib + Navitoclax in recurrent ovarian carcinoma
-
批准号:10684234
-
项目类别:
-
资助金额:$38.34万
-
财政年份:2020
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Evaluation of the Efficacy of Trametinib + Navitoclax in recurrent ovarian carcinoma
-
批准号:10469377
-
项目类别:
-
资助金额:$54.12万
-
财政年份:2020
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Developmental Research Program (DRP)
-
批准号:10024421
-
项目类别:
-
资助金额:$17.57万
-
财政年份:2020
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Program 02: Gynecologic Cancers
-
批准号:10332564
-
项目类别:
-
资助金额:$4.2万
-
财政年份:1997
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Program 02: Gynecologic Cancers
-
批准号:10540423
-
项目类别:
-
资助金额:$4.2万
-
财政年份:1997
-
负责人:URSULA Anne MATULONIS
-
依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈立达
-
依托单位: